JOURNAL ARTICLE
REVIEW

[Assessment of bone quality. Drug developments for restoring bone mass and quality in the treatment of osteoporosis]

Toshitaka Nakamura
Clinical Calcium 2008, 18 (3): 374-80
18310826
To improve bone mass and quality two strategies are currently taken ; one is the indirect stimulation of bone formation through the endogenous parathyroid function augmented by anti-resorptive agents that do not have a direct suppressive effect on the osteoblastic function, and the other is the direct osteoblast stimulation by agents themselves. The former group includes anti-RANKL antibody and cathepsin K inhibitors and the latter has strontium ranelate, teriparatide, and anti-sclerostin antibody. Clinical data of these drugs in osteoporosis are expected.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Remove bar
Read by QxMD icon Read
18310826
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"